ask="N/A"
ask_size="N/A"
average_daily_volume="271608"
bid="32.25"
bid_size="100"
book_value="7.07"
change="+1.56"
change_from_200_day_moving_average="1.01"
change_from_50_day_moving_average="0.97"
change_from_52_week_high="-6.74"
change_From_52_week_low="17.18"
change_in_percent="+5.09%"
close="32.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.26"
ebitda="-177.88M"
eps_estimate_current_year="-4.00"
eps_estimate_next_quarter="-1.13"
eps_estimate_next_year="-3.98"
ex_dividend_date="N/A"
float_shares="28541000"
high="32.28"
high_52_weeks="38.92"
last_trade_date="3/1/2017"
last_trade_price="32.18"
last_trade_size="29606"
last_trade_time="4:00pm"
low="30.63"
low_52_weeks="15.00"
market_capitalization="1.60B"
moving_average_200_day="31.17"
moving_average_50_day="31.21"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="31.15"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+3.25%"
percent_change_from_50_day_moving_average="+3.12%"
percent_change_from_52_week_high="-17.32%"
percent_change_from_52_week_low="+114.53%"
previous_close="30.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.33"
price_per_sales="31.20"
revenue="48.65M"
shares_outstanding="49569000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="334474"
weeks_range_52="15.00 - 38.92"
